Pinhasov, Albert

Cloning and Characterization of the Human Activity-dependent Neuroprotective Protein

Zamostiano, R., Pinhasov, A., Gelber, E., Steingart, R. A., Seroussi, E., Giladi, E., Bassan, M., Wollman, Y., Eyre, H. J., Mulley, J. C., et al. (2001) · Journal of Biological Chemistry

Cancer-related Molecular PathwaysCancer Mechanisms and Therapy

Cited by 251

Activity-dependent neuroprotective protein: a novel gene essential for brain formation

Pinhasov, A., Mandel, S., Torchinsky, A., Giladi, E., Pittel, Z., Goldsweig, A. M., Servoss, S. J., Brenneman, D. E., & Gozes, I. (2003) · Developmental Brain Research

Neurogenesis and neuroplasticity mechanismsDevelopmental Biology and Gene Regulation

Cited by 239

Activity-Dependent Neuroprotective Protein Snippet NAP Reduces Tau Hyperphosphorylation and Enhances Learning in a Novel Transgenic Mouse Model

Vulih-Shultzman, I., Pinhasov, A., Mandel, S., Grigoriadis, N., Touloumi, O., Pittel, Z., & Gozes, I. (2007) · The Journal of Pharmacology and Experimental Therapeutics

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 219

A historical perspective on clonidine as an alpha-2A receptor agonist in the treatment of addictive behaviors: Focus on opioid dependence

Gold, M. S., Blum, K., Bowirrat, A., Pinhasov, A., Bagchi, D., A. Dennen, C., K. Thanos, P., Hanna, C., Lewandrowski, K.-U., Sharafshah, A., et al. (2024) · INNOSC Theranostics and Pharmacological Sciences

Opioid Use Disorder TreatmentSubstance Abuse Treatment and Outcomes

Cited by 9

Solving the Global Opioid Crisis: Incorporating Genetic Addiction Risk Assessment with Personalized Dopaminergic Homeostatic Therapy and Awareness Integration Therapy

Zeine, F., Jafari, N., Baron, D. A., Bowirrat, A., Pinhasov, A., Norling, B., Martinez, K. C., Nami, M., Manavi, N., Sunder, K. R., et al. (2024) · Journal of Addiction Psychiatry

Opioid Use Disorder TreatmentSubstance Abuse Treatment and Outcomes

Cited by 3